Picture of Eris Lifesciences logo

ERIS Eris Lifesciences Balance Sheet

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Annual balance sheet for Eris Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments3,2241,4218731,504860
Net Total Accounts Receivable
Net Total Receivables1,4052,1062,1892,7084,590
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets5,8184,7964,6706,2737,647
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment5618737791,9193,774
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets15,53715,52318,34822,72136,673
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities3,0551,6471,6691,9964,432
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities4,0312,5602,5843,63814,713
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity11,50512,96315,76419,08321,960
Total Liabilities & Shareholders' Equity15,53715,52318,34822,72136,673
Total Common Shares Outstanding